RESPIROLOGY 润色咨询

RESPIROLOGY

出版年份：1996 年文章数：1234 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：19.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2020-08-22 Ardilla

    提交一周后，拒了说是研究设计不是前瞻性的😒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2020-03-07 980353895_92754195

    能请教一下大家respirology的版面费要多少吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2018-02-13 877172541_52819444

    审稿速度:1.0
    经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2017-08-24 lingzhai

    在三分上保持住了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2017-06-14 eydyl

    不合适，偏临床的杂志JPDXQ 2017-03-10 发表::
    各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？    JPDXQ 2017-03-10 21:15:00 发表:
    各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？

    JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2017-03-10 JPDXQ

    各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2016-08-23 不易

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2016-05-08 sunny明

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿1月后大修，大修1月后被拒。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2016-01-29 510174

    15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=812035, encodeId=04e7812035ab, content=提交一周后，拒了说是研究设计不是前瞻性的😒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/e39bae502df27cdf94b4a60992c2e93f.jpg, createdBy=fa2a2332777, createdName=Ardilla, createdTime=Sat Aug 22 14:45:38 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586094, encodeId=2c4c5860940e, content=能请教一下大家respirology的版面费要多少吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ceb5310685, createdName=980353895_92754195, createdTime=Sat Mar 07 11:49:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552667, encodeId=2bc855266e37, content=审稿速度:1.0<br>经验分享：1月31日投稿，2月1日要求重新提交图片和润色，并推荐了润色公司，经过一周润色，2月8日再次提交，2月10日拒稿，说中药作用通路和西药不一样，meta分析接受率只有20%，所以拒稿。因为主题原因拒稿为什么还要让我润色……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=348e2239946, createdName=877172541_52819444, createdTime=Tue Feb 13 18:15:00 CST 2018, time=2018-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545857, encodeId=96ae54585e11, content=在三分上保持住了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14d3109845, createdName=lingzhai, createdTime=Thu Aug 24 09:52:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537760, encodeId=c84253e760fb, content=不合适，偏临床的杂志<span class="quote">JPDXQ 2017-03-10 发表::<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span><span class="quote">JPDXQ 2017-03-10 21:15:00 发表:<br>各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？</span>, beContent=JPDXQ 2017-03-10 发表:: 各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7aaa1624970, createdName=eydyl, createdTime=Wed Jun 14 00:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533995, encodeId=a83f53399503, content=各位前辈，我做的是肺纤维化动物实验的基础研究，主要免疫荧光和分子生物学指标，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:15:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526210, encodeId=ffab526210ed, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：投过几次，接收很难，分数不高，要求很高，最近几年越来越傲气了，各种理由都可以拒稿，不太欢迎meta分析类文章，编辑说接收率20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3ee1693213, createdName=不易, createdTime=Tue Aug 23 23:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522128, encodeId=6b52522128bc, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿1月后大修，大修1月后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=270c1709474, createdName=sunny明, createdTime=Sun May 08 12:38:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518885, encodeId=18ad518885a5, content=15年9月初投稿，三个月后一审意见major revision，大修20天后accept。一审找审稿人就花了一个多月，总的来说速度虽然不快，但杂志编辑还比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6ea1447264, createdName=510174, createdTime=Fri Jan 29 19:22:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518345, encodeId=fbd2518345bd, content=投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca8b1434931, createdName=yangli_018, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=)]
    2016-01-12 yangli_018

    投稿6周后被拒了，主编说接受比例20%。请教了一下科室的前辈，都说这杂志分数不高，审稿人要求高。唉，悲惨！

    0

共43条页码: 2/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分